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etymologia
Kobuvirus
The Japanese term kobu (kō′ bü), meaning hump or knob, was chosen to designate this genus in the family 
Picornaviridae because of the distinctive icosahedral structure of the viruses in this group. The genus contains the 
species Aichi virus and Bovine kobuvirus, and a candidate porcine kobuvirus has been identified. Aichi virus, the 
type species, was first recognized in 1989 as the cause of oyster-associated nonbacterial gastroenteritis in persons 
in the Aichi Prefecture in Japan.
Source:  Mahy B. The dictionary of virology, 4th edition. London: Elsevier; 2009; Pringle CR. Virus taxonomy at the XIth International 
Congress of Virology, Sydney, Australia, 1999. Arch Virol 1999; 144:2066–70.